QUANTUM ACOUSTICS
Dead / Cancelled — Cancelled — Section 8 (as of 08 Aug 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86983249
- Registration number
- 5347107
- Mark type
- Stylized text
- Filed
- 15 Oct 2014
- Published for opposition
- 22 Mar 2016
- Registered
- 28 Nov 2017
- Attorney of record
- Douglas N. Masters
Goods and services
- Class 009 — Scientific and electric apparatus: acoustical membranes; acoustical stand alone and movable screens for enhancing audio sounds
- Class 019 — Non-metallic building materials: non-metal acoustical products, namely, aesthetic acoustic wall panels, curtain walls in flexible format
- Class 042 — Scientific and technological services: consulting services in the field of acoustic design for others; scientific services, namely, research and development of new acoustic products for others; architectural design services for others in the field of acoustics
Owner
- Hanson Hsu, Campbell, CA, US
- Hanson Hsu, Marina del Rey, CA, US
- Hanson Hsu, Marina del Rey, CA, US
Prosecution history
- 08 Aug 2025 — NOTICE OF CANCELLATION SEC. 8 EMAILED
- 08 Aug 2025 — CANCELLED SEC. 8 (6-YR)
- 19 Jan 2025 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 24 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 24 Jun 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 24 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Nov 2023 — TEAS SECTION 8 & 15 RECEIVED
- 28 Nov 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Nov 2017 — REGISTERED-PRINCIPAL REGISTER
- 26 Oct 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Oct 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Oct 2017 — DIVISIONAL PROCESSING COMPLETE
- 08 May 2017 — DIVISIONAL REQUEST RECEIVED
- 19 Oct 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 May 2017 — TEAS REQUEST TO DIVIDE RECEIVED